Clinical Trial Update: A Study of LUCAR-20SP in Subjects With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of LUCAR-20SP in relapsed or refractory B-cell non-Hodgkin lymphoma is currently recruiting at a Chinese cancer center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma

Drugs mentioned

• LUCAR-20SP

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Relapsed B-cell Non-Hodgkin Lymphoma, Refractory B-cell Non-Hodgkin Lymphoma | Phase 1 | Status: RECRUITING